Sony Xperia 1 VIII FCC Certification Hints at Earlier Launch, Headphone Jack and New Design

April 15, 2026
Sony Xperia 1 VIII FCC Certification Hints at Earlier Launch, Headphone Jack and New Design

Tokyo, April 16, 2026, 02:16 JST

Sony’s next flagship—expected to go by Xperia 1 VIII—has surfaced in fresh paperwork at the U.S. Federal Communications Commission with FCC ID PY7-30515Z. According to those filings, the device is set for 5G, Wi-Fi 7 support, and wireless charging. Observers combing through the FCC docs point out Sony isn’t ditching the 3.5 mm headphone jack, even as most top-tier phones have left it behind.

What stands out here is the timing: this filing emerged just before the Xperia 1 VII appeared at the FCC last year, sparking talk that Sony might push up its flagship release and go head-to-head with Samsung’s Galaxy S26 lineup sooner than expected. It’s happening while leading phone makers are dealing with pricier parts. “Vendors have little choice but to raise prices,” said Omdia principal analyst Sanyam Chaurasia. But higher prices could trigger a “demand shock” that keeps customers on the sidelines, warned his colleague Runar Bjorhovde. Notebookcheck

In a landscape where fresh hardware still attracts plenty of attention, that stands out. Omdia’s senior analyst Lucas Zhong singles out “meaningful innovation in flagship and foldable devices” as something that could help steady demand this year, mentioning Xiaomi’s 17 Ultra as an example. Sony, then, has even less margin for error with its next update. Omdia

The FCC filing doesn’t give much away on the commercial end, but the page lays out several features: Bluetooth, NFC, satellite positioning, and Wi-Fi 7 (802.11be) are in the mix. WPT—meaning wireless power transfer, or simply wireless charging—gets a mention as well. For testing, Sporton International in Taiwan is handling that part.

Leaks are coming faster now. Over the last two weeks, Gadgets360, Mezha, and PhoneArena have all pointed to a square rear camera housing with three lenses. The front design’s less clear: some renders show a punch-hole selfie cam, while others keep Sony’s usual thick top bezel and front-facing speakers.

Sony’s smartphone website continues to feature just the Xperia 1 VII and Xperia 10 VII; there’s no sign of a new model yet. The Xperia 1 VII launched back on May 13, 2025, with a European price tag of about 1,499 euros or 1,399 pounds. Citing buzz from a Vietnamese Sony fan group and leaker Chunvn888, Notebookcheck reported Wednesday that the VIII could roll out globally in May, with Vietnam getting it as late as July. Still, nothing is confirmed.

The Xperia 1 VII, Sony’s 2025 flagship, shows where the company is drawing its line as it updates the design. Sony is touting AI Camerawork, hints of Walkman heritage, and display tech tuned with BRAVIA know-how. On the support pages, you’ll spot the familiar 3.5 mm jack, eSIM for one model, microSD for another—core Xperia traits the brand refuses to drop.

Many specifics are still unsettled. The FCC filings make no mention of the device’s name, and the latest renders send mixed signals—some ditch the big bezels with a punch-hole camera, some stick to the old look. Sony hasn’t done much to resolve worries after halting Xperia 1 VII sales in eligible European countries last July, with reports piling up about devices shutting off, rebooting, or refusing to turn on. Sales picked up again in August.

Right now, Sony’s upcoming flagship is working its way through regulators, with filings and leaks hinting at a fresh look, but sticking close to Xperia hallmarks. The name, launch window, and destination markets? Sony hasn’t officially said.

Technology News Today

  • CRISPR variant ThermoCas9 targets tumor DNA via methylation fingerprint
    April 15, 2026, 1:47 PM EDT. Researchers from Wageningen University & Research and the Van Andel Institute report a CRISPR variant, ThermoCas9, that distinguishes tumor DNA from healthy DNA by DNA methylation-chemical tags that regulate gene activity. In Nature, the team shows ThermoCas9's PAM includes a human methylation site, allowing it to bind methylated DNA and cut tumor genomes while sparing unmethylated healthy DNA in cultured cells. The work marks the first CRISPR-based method to use methylation to target human cancer cells. While promising, results in cell culture are early and require validation in animals and, later, humans. If developed, this epigenetic fingerprint approach could yield highly selective cancer therapies that target malignant cells while leaving healthy tissue intact.